Skip to main content
Caplight Logo









Beijing Datsing Bio-Tech Co., Ltd.

Beijing Datsing Bio-Tech Co., Ltd.

Private
BeijingHealthcare & Life Scienceshttps://www.datsing.com/

Last Round

Private Equity

Jul 10, 2026

Total Funding Raised

$20.62M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Beijing Datsing Bio-Tech Co., Ltd. operates in Healthcare & Life Sciences and is based in Beijing. Its latest recorded funding round was a Private Equity round in July 2026.

Beijing Datsing Bio-Tech Co., Ltd. is a biotechnology company that develops, manufactures, and markets medical products for wound management, minimally invasive surgery, stomatology, and regenerative medicine.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Beijing Datsing Bio-Tech Co., Ltd. Comparables

Compare Beijing Datsing Bio-Tech Co., Ltd. with similar companies based on industry and business-model similarity.

Beijing Datsing Bio-Tech Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Success Bio-Tech Co., Ltd.
87%
CuraMedical B.V.
84%
Hangzhou Singclean Medical Products Co., Ltd.
84%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Beijing Datsing Bio-Tech Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityJul 10, 2026
Series CJan 1, 2019
Series BAug 1, 2014
Series AMay 1, 2013
SeedSep 1, 2009
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Beijing Datsing Bio-Tech Co., Ltd. Investors

Notable investors and investment history

Beijing Datsing Bio-Tech Co., Ltd. investors
InvestorRounds
Northern Light Venture CapitalSeries B
China Science and Technology Industry Investment ManagementSeries C
Tsinghua Innovation VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 10, 2026

    $9.24M round led by Nanjing Pharmaceutical Group Company Limited.

  • Jan 1, 2019

    Raised Series C round with China Science and Technology Industry Investment Management.

Book a demo to see all signals

For institutional investors. Book with your work email.

Beijing Datsing Bio-Tech Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Beijing Datsing Bio-Tech Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Beijing Datsing Bio-Tech Co., Ltd.'s valuation, stock price, and market status.

Is Beijing Datsing Bio-Tech Co., Ltd. a public or private company?

Beijing Datsing Bio-Tech Co., Ltd. is a private company.

What is the current stock price of Beijing Datsing Bio-Tech Co., Ltd.?

Beijing Datsing Bio-Tech Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Beijing Datsing Bio-Tech Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Beijing Datsing Bio-Tech Co., Ltd. worth (valuation)?

Valuation information for Beijing Datsing Bio-Tech Co., Ltd. is not publicly available.

Can I buy Beijing Datsing Bio-Tech Co., Ltd. stock?

Beijing Datsing Bio-Tech Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Beijing Datsing Bio-Tech Co., Ltd.'s last funding round?

Beijing Datsing Bio-Tech Co., Ltd.'s most recent funding round was Private Equity on July 10, 2026.

Who are the main investors in Beijing Datsing Bio-Tech Co., Ltd.?

Key investors in Beijing Datsing Bio-Tech Co., Ltd. include Northern Light Venture Capital, China Science and Technology Industry Investment Management, Tsinghua Innovation Ventures.

Will Beijing Datsing Bio-Tech Co., Ltd. IPO soon?

No public IPO plans have been announced for Beijing Datsing Bio-Tech Co., Ltd..

How can I track Beijing Datsing Bio-Tech Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Beijing Datsing Bio-Tech Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersBeijing
Employee Range27
Year Founded2001
Last FundingJul 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?